Literature DB >> 16033103

Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells.

Veit Zieglschmid1, Christiane Hollmann, Bertha Gutierrez, Winfried Albert, Dark Strothoff, Eberhard Gross, Oliver Böcher.   

Abstract

BACKGROUND: A highly specific and sensitive tumor cell detection assay is reported, which combines immunomagnetic enrichment with multiplex RT-PCR analysis.
MATERIALS AND METHODS: The effect on the recovery rate of breast, testicular and colorectal cancer cells using single antibodies and combinations of them for IMS was examined by fluorescence microscopy and multiplex RT-PCR. The clinical utility of a tumor cell detection assay using IMS with multiplex RT-PCR was tested by examination of colorectal cancer blood samples and by comparing the results with CEA serum protein levels.
RESULTS: A combination of antibodies for IMS and multiplex RT-PCR analysis proved to be the most sensitive approach for detection of tumor cells in peripheral blood with a detection limit of two tumor cells. The examination of blood of colorectal cancer patients by using a multiplex RT-PCR assay in comparison with CEA serum protein levels indicated a distinct advantage of the former over the latter with respect to a more reliable prediction of an ongoing metastatic process.
CONCLUSION: The results indicate that a combination of antibodies for immunomagnetic enrichment with multiplex RT-PCR analysis detects disseminated tumor cells with high sensitivity and specificity, thus indicating a metastatic process several months earlier compared to CEA serum protein level measurements. This assay might be valuable for prognosis in cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16033103

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  25 in total

Review 1.  The promise of circulating tumor cells for precision cancer therapy.

Authors:  William L Hwang; Katie L Hwang; David T Miyamoto
Journal:  Biomark Med       Date:  2016-12-07       Impact factor: 2.851

2.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 3.  Molecular analysis of circulating tumour cells-biology and biomarkers.

Authors:  Matthew G Krebs; Robert L Metcalf; Louise Carter; Ged Brady; Fiona H Blackhall; Caroline Dive
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

4.  Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.

Authors:  Reza Yadegarazari; Taghi Hassanzadeh; Amir Majlesi; Amir Keshvari; Alireza Monsef Esfahani; Amirsasan Tootoonchi; Nooshin Shabab; Massoud Saidijam
Journal:  Iran Biomed J       Date:  2013

Review 5.  Circulating tumor cell isolation, culture, and downstream molecular analysis.

Authors:  Sandhya Sharma; Rachel Zhuang; Marisa Long; Mirjana Pavlovic; Yunqing Kang; Azhar Ilyas; Waseem Asghar
Journal:  Biotechnol Adv       Date:  2018-03-17       Impact factor: 14.227

6.  Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.

Authors:  Tanja Fehm; Oliver Hoffmann; Bahriye Aktas; Sven Becker; Erich F Solomayer; Diethelm Wallwiener; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Breast Cancer Res       Date:  2009-08-10       Impact factor: 6.466

7.  Circulating tumor cells as markers for cancer risk assessment and treatment monitoring.

Authors:  Sabine Kasimir-Bauer
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer.

Authors:  Silke Lankiewicz; Silke Zimmermann; Christiane Hollmann; Tina Hillemann; Tim F Greten
Journal:  Mol Oncol       Date:  2008-09-16       Impact factor: 6.603

9.  Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis.

Authors:  Xiaoshen Dong; Katherine R Alpaugh; Massimo Cristofanilli
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

10.  Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.

Authors:  I Van der Auwera; D Peeters; I H Benoy; H J Elst; S J Van Laere; A Prové; H Maes; P Huget; P van Dam; P B Vermeulen; L Y Dirix
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.